AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64%

CC5 Clever Culture Systems Limited

Technology · Software - Infrastructure · website
$0.02
52wk 0.02 – 0.04
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Clever Culture Systems Limited

Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, China, Netherlands, and Germany. The company offers Automated Plate Assessment System, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; Digital Microbiology; and APAS modules, an artificial intelligence algorithm that work with the APAS Independence to enable digital microbiology culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes urine screening, infection control testing, and antimicrobial susceptibility testing. The company was formerly known as LBT Innovations Limited and changed its name to Clever Culture Systems Limited in November 2024. Clever Culture Systems Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$34.87M
P/E (trailing)
P/E (forward)
EPS (trailing)
0.00
Dividend yield
Payout ratio
0.0%
Beta
1.69
EV / EBITDA
-14.02
Price / Book
4.00
ROE
-11.6%
Operating margin
-63.5%
Net margin
-14.4%
Total cash
$3.10M
Total debt
$1.31M
Current ratio
2.81
Debt / Equity
0.16
Free cash flow
$-1.20M
Avg volume
813,135
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$5.46M
  • Gross profit$3.96M
  • Operating income-$1.17M
  • Net income$1.68M
  • Diluted EPS0.00
  • Free cash flow-$1.17M
  • Net debt$950.00K
Sector peers (Technology)
TickerMkt cap P/EScore
NXT $10.25B
CDA $7.29B 56.5
360 $6.21B 30.4
NWL $5.50B 97.5
MP1 $4.35B
DDR $2.29B 26.8
MAQ $1.59B 48.1
DTL $1.51B 30.4